The FDA has approved Sofdra gel 12.45% for the treatment of primary axillary hyperhidrosis in adults and children aged 9 years and older, Botanix Pharmaceuticals announced in a press release ...

Axillary hyperhidrosis is a medical condition in which the body produces excessive sweat in underarms. The individuals with axillary hyperhidrosis sweat up to five times the amount that is ...

(HealthDay)—For patients with axillary hyperhidrosis, the optimal treatment option is laser at 924/975 nm combined with curettage, according to a study published online Feb. 6 in Lasers in ...

Source Reference: Chilukuri S, et al "Primary axillary hyperhidrosis treatment using high intensity focused fractional radiofrequency microneedling" J Drugs Dermatol 2018; 17 (7): 745-748.

For axillary hyperhidrosis patients with unsatisfactory response to topical options, the next step in the algorithm is oral systemic medication, including anticholinergics (glycopyrrolate ...

About Hyperhidrosis Hyperhidrosis is a condition of sweating beyond what is physiologically required for normal thermal regulation and affects an estimated 4.8% of the U.S. population, or ...

A 4-week follow-up revealed 13 patients (86.67%) with complete axillary anhidrosis. After 3 months, 11 (73.33%) of the 15 patients had dryness of the axillary skin.

Qbrexza (glycopyrronium; Dermira) has been made available for the treatment of primary axillary hyperhidrosis in adults and pediatric patients ≥9 years old. Qbrexza is supplied as a single-use ...

Dermira announced that the Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth for the topical treatment of primary axillary hyperhidrosis in patients aged ≥9 years ...

Candesant's investigational Patch is currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of primary axillary hyperhidrosis or excessive underarm sweating.

The global axillary hyperhidrosis treatment market is valued at USD 1.91 billion in 2025 and is expected to reach USD 3.42 billion by 2035, which shows a CAGR of 6%. Demand is being propelled by ...

While hyperhidrosis is not a life-threatening condition, it does have many social and psychological effects -- patients may be stigmatized and isolated in society. Many therapies, topical and ...